RU96123360A - METHOD FOR TREATING SEPSIS IN NEWBORNS - Google Patents

METHOD FOR TREATING SEPSIS IN NEWBORNS

Info

Publication number
RU96123360A
RU96123360A RU96123360/14A RU96123360A RU96123360A RU 96123360 A RU96123360 A RU 96123360A RU 96123360/14 A RU96123360/14 A RU 96123360/14A RU 96123360 A RU96123360 A RU 96123360A RU 96123360 A RU96123360 A RU 96123360A
Authority
RU
Russia
Prior art keywords
newborns
treating sepsis
sepsis
treating
aminoglycosides
Prior art date
Application number
RU96123360/14A
Other languages
Russian (ru)
Other versions
RU2147881C1 (en
Inventor
В.В. Эстрин
О.В. Муравьев
Е.А. Ефанова
Original Assignee
Ростовский научно-исследовательский институт акушерства и педиатрии
Filing date
Publication date
Application filed by Ростовский научно-исследовательский институт акушерства и педиатрии filed Critical Ростовский научно-исследовательский институт акушерства и педиатрии
Priority to RU96123360A priority Critical patent/RU2147881C1/en
Priority claimed from RU96123360A external-priority patent/RU2147881C1/en
Publication of RU96123360A publication Critical patent/RU96123360A/en
Application granted granted Critical
Publication of RU2147881C1 publication Critical patent/RU2147881C1/en

Links

Claims (1)

Способ лечения сепсиса у новорожденных путем назначения антибактериального препарата, отличающийся тем, что предварительно в сыворотке крови больного методом иммуноферментного анализа определяют титры антител к выделенным в отделении микроорганизмам и при повышении их в 3 и более раз от исходного дополнительно назначают аминогликозиды.A method of treating sepsis in newborns by administering an antibacterial drug, characterized in that the titers of antibodies to microorganisms isolated in the department are determined in the patient’s blood serum by enzyme-linked immunosorbent assay and, when they are increased 3 or more times from the initial, aminoglycosides are additionally prescribed.
RU96123360A 1996-12-10 1996-12-10 Method for treating sepsis in newborns RU2147881C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU96123360A RU2147881C1 (en) 1996-12-10 1996-12-10 Method for treating sepsis in newborns

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96123360A RU2147881C1 (en) 1996-12-10 1996-12-10 Method for treating sepsis in newborns

Publications (2)

Publication Number Publication Date
RU96123360A true RU96123360A (en) 1999-01-20
RU2147881C1 RU2147881C1 (en) 2000-04-27

Family

ID=20187987

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96123360A RU2147881C1 (en) 1996-12-10 1996-12-10 Method for treating sepsis in newborns

Country Status (1)

Country Link
RU (1) RU2147881C1 (en)

Similar Documents

Publication Publication Date Title
DE69008423D1 (en) Dynamic fixation of porcine acid valves.
FR12C0004I2 (en) ANTIBODIES TO HUMAN CTLA-4 ANTIGEN AND USE
DE68909691D1 (en) Multi-layer body for the delivery of fragrances.
DE68907519T2 (en) Biosensors.
DE69129302D1 (en) TUMOR GROWTH INHIBITORS FROM FABRICS, METHODS OF THEIR PRODUCTION AND USE
DE68925226D1 (en) Monoclonal antibodies
FI961083A (en) Recombinant IL4 antibodies useful in the treatment of IL-4-mediated disorders
DE3872754D1 (en) DETECTION OF ANTIBODY HUMAN IMMUNDEFIZIENZ VIRUS.
DE3889062T2 (en) Monoclonal antibody against human BCDF.
DE68918217D1 (en) Family of modified antibodies with high affinity for the treatment of cancer.
DZ2028A1 (en) Medicines used to treat bacterial infections in pediatrics.
EP0350690A3 (en) Neutralisation of the in vitro and in vivo toxic properties of tnf-alpha by monoclonal antibodies and by fragments derived therefrom
UA24003A (en) Method for determination of specific sensitization of lymphocytes
NO973875L (en) Method of Stimulating an Immune Response
DE69841966D1 (en) A pharmaceutical or nutritional composition for the treatment of pathologies associated with a graft rejection
IT1284076B1 (en) F(AB')2 FRAGMENTS AND THEIR IMMUNOGLOBULINS IGG, ACTIVE AS SPECIFIC ANTIBODY TOWARDS DRUGS AND THEIR METABOLITES, AND THEIR
FI101797B1 (en) STLV-III virus related polypeptides, diagnostic systems, and assay methods
FR2804027B1 (en) USE OF MONOCLONAL ANTI-FERRITIN ANTIBODIES IN THE TREATMENT OF CERTAIN CANCERS
DE3888437T2 (en) Immobilized antibodies.
RU96123360A (en) METHOD FOR TREATING SEPSIS IN NEWBORNS
EP0313005A3 (en) Method for detecting carcinomatous and precarcinomatous colo-rectal disease
NO905496D0 (en) BIOLOGICAL COMPATIBLE, SUBSTANCE-SPECIFIC REAGENTS FOR TREATMENT OF PHYSIOLOGICAL LIQUIDS.
DE68907377D1 (en) AGENTS AND DEVICES FOR DETERMINING ANTIGENS OR ANTIBODIES.
DE520834T1 (en) Pharmaceutical composition containing PP14 or antibodies against PP14 for the treatment of immune system disorders.
JPS52154520A (en) Modified antibody and its preparation